Rheumatoid Arthritis

Top Story

CNT0675 seen as safe, but not effective in treatment of MTX-resistant RA

November 15, 2017

In patients with rheumatoid arthritis that is refractory to methotrexate therapy, the human monoclonal antibody CNT06785 is well tolerated but does not appear to be clinically effective, according to findings.

Meeting News

Age, low CRP levels increase odds of successful tapering of biologics in RA

November 8, 2017
SAN DIEGO — Younger age, no concomitant steroid use and low C-reactive protein increased the rate of successful tapering of biologic drugs in patients with…
Meeting News

Behavioral intervention improved healthy behaviors, reduced flare frequency in RA

November 8, 2017
SAN DIEGO — A telephone-based behavioral intervention was associated with more frequent exercise and reduced tobacco and alcohol consumption in patients with…
Meeting NewsVideo

VIDEO: Improved physical function for patients with RA when switched from adalimumab to sarilumab

November 8, 2017
SAN DIEGO — At the American College of Rheumatology Annual Meeting, Gerd R. Burmester, MD, spoke about the efficacy and safety of switching from adalimumab to…
More Headlines »
CME ABIM MOC

Ace the Case: A 50-Year-Old White Female with a 9-Year History of Rheumatoid Arthritis

There is no commercial support for this activity.

This “Ace the Case” study will explore the diagnosis and management of a 50-year-old white female with a 9-year history…
More »
Video
Meeting News

VIDEO: Harrold reviews study on rituximab to treat RA

December 9, 2016
More »
Resource Centers
American College of Rheumatology Annual Meeting

American College of Rheumatology Annual Meeting

Advertisement
Advertisement